Posts Tagged ‘Life Sciences’

Let’s tackle a tough one… It’s one thing to put IBM Maximo, an enterprise asset management solution, in the cloud. It’s something completely different to put IBM Maximo in an FDA-compliant cloud!  At Perficient, we don’t do the usual – we cater to the difficult and never been done before, crowd. Our cloud has been serving […]

In a recent blog post, I mentioned the three critical themes for success in the digital age, as identified by McKinsey & Company through interviews with 20 pharma executives: 

Last week, I wrote a post about an article published by McKinsey & Company in which they interviewed 20 pharma executives about how they’re handling digital transformation. The article was jam-packed with great information, so I wanted to highlight a few more points for you. 

In 2015, companies in all industries experienced data security breaches. From Anthem, one of the nation’s leading health benefits companies, to the UCLA Health System, all the way to Hzone, a matchmaking mobile application for HIV positive singles, no company was safe from a data breach. Increasing data privacy and security is a trend that […]

  In a recent article, McKinsey & Company shared the results of 20 interviews with leading executives in pharma about the “digital revolution.” Through the interviews, McKinsey sought to learn how pharma companies plan to stay ahead of inherent changes in the age of digital. 

  Demographics in clinical trials have always been scrutinized by the medical community and the public. Are various races, ethnicities, sexes, and ages fairly represented in trials? Does one segment respond better or worse than another to a particular treatment? These questions and more are being answered in the Drug Trials Snapshots section of the […]

Last month, I read an article on the announcement from Apple’s CEO Tim Cook that stated Eli Lilly bought 15,000 iPads. The article, focusing on Apple’s mobility partner program, framed this as big news about Apple. I assume this will also significantly contribute to the Apple and IBM partnership as they build big data and analytics enterprise […]

  Real-world data, the data generated about drugs and devices in real-world settings (e.g., routing doctor visits, hospital stays, etc.), can help develop more accurate product profiles. This is because the data comes from products that are no longer confined to the smaller, homogenous populations involved in clinical trials. More comprehensive profiles can help better […]

  Oracle’s third quarter 2016 earnings call was peppered with strong revenues and big wins in various categories. But what was most striking was the incredible progress the enterprise software powerhouse has made with regard to the cloud. Between CEO Safra Catz, CEO Mark Hurd (yes, they’re both CEOs), and Executive Chairman of the Board […]

  In my tenure here at Perficient, I’ve contributed to a number of guides for the life sciences industry. Each one has been informative and useful, but I can’t remember ever being as excited about any of them as I am about the newest one: Life Sciences is Going Digital. 

Medication non-adherence continues to be a big issue in the pharma industry, affecting clinical outcomes for both approved and investigational drugs. Sponsors, research organizations, and payers are looking to verify that what they’re studying or paying for is actually being used as directed. Various technologies, such as Proteus and AiCure, are being examined for these […]

  The life sciences industry is truly a global marketplace. Companies reside all over the map, and now more than ever, pharmaceutical companies and contract research organizations are choosing to move their headquarters overseas, to places like Ireland, where they are more tax-friendly. Whether born and bred in Ireland or a recent transplant, the island […]